Pulmonx

Pulmonx

Minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.

Launch date
Employees
Market cap
AUD503m
Enterprise valuation
AUD413m (Public information from Sep 2024)
Redwood City California (HQ)
Authorizing premium user...